Research Article

Preparation of Folate-Conjugated Pluronic F127/Chitosan Core-Shell Nanoparticles Encapsulating Doxorubicin for Breast Cancer Treatment

Table 2

Cellular uptake of DOX by MCF-7 cells treated with free DOX, DOX-loaded chitosan nanoparticles, and DOX-loaded folate-conjugated chitosan nanoparticles for up to 24 hours. Results are presented as percent of the initial concentration of DOX.

ConditionsCellular DOX uptake (% of its initial concentration)
1 h2 h6 h12 h18 h24 h

Free DOX 2 6 . 8 ± 0 . 5 8 8 0 ± 1 . 3 7 4 . 7 ± 2 . 1 9 8 . 0 ± 1 . 7 9 3 . 7 ± 2 . 7 1 0 2 . 8 ± 4 . 4
DOX-loaded micelles coated with chitosan 0 . 5 ± 0 . 1 0 . 6 ± 0 . 2 2 . 7 ± 0 . 6 4 . 5 ± 1 . 0 1 1 . 2 ± 0 . 8 1 4 . 7 ± 1 . 5
DOX-loaded micelles coated with modified chitosan 0 . 6 ± 0 . 4 0 . 7 ± 0 . 6 1 0 . 9 ± 0 . 7 1 2 . 7 ± 0 . 7 2 1 . 1 ± 1 . 9 2 6 . 3 ± 1 . 9